NAD+ therapy in 2026: what the latest research shows
NAD+ research keeps moving, so it is worth checking in each year. Human studies show that NAD+ levels can be raised reliably and that NAD+ precursors are well tolerated, and newer trials are exploring what that means for energy, the heart and healthy aging.
What does the latest research show about NAD+ therapy?
The most consistent finding across human trials is that NAD+ levels can be raised. Precursors such as nicotinamide riboside (NR) and NMN reliably increase NAD+ in the blood, and studies report they are well tolerated. Researchers are now building on that foundation with trials on energy, heart function and healthy aging. NAD+ therapy is an active, emerging area of research, and a consultation is the best way to learn how it may fit your goals.
NAD+ precursors: well tolerated, with higher NAD+ levels
In a randomized, placebo-controlled crossover trial, six weeks of nicotinamide riboside was well tolerated and raised NAD+ levels in healthy middle-aged and older adults. A separate study found that a single dose of NR raised NAD+ levels in the human brain within hours. Together, these studies show that NAD+ in the body responds to supplementation.
IV NAD+ and heart function
A randomized, placebo-controlled trial published in the American Journal of Cardiovascular Drugs studied patients with heart failure caused by ischemic cardiomyopathy. Patients who received intravenous NAD+ for seven days alongside standard care showed improved heart function compared with placebo. It is a notable clinical study of IV NAD+, and research in this area continues.
Why sourcing and preparation matter
Products used for NAD+ therapy are compounded, so where your NAD+ comes from and how it is prepared matters. Injectable NAD+ should be prepared by a licensed pharmacy to sterile standards. Asking about sourcing is a normal, welcome question, and the APRM Solutions team is glad to walk you through it during your consultation.
What this means if you are considering NAD+ therapy
The research supports a simple path: start with a consultation. Your provider reviews your health history and medications, explains what the latest studies mean for your goals, confirms how the product is sourced and prepared, and recommends the option that fits you. For the questions worth asking before you book, see our guide to NAD+ therapy questions to ask.
Further reading from trusted sources
- Nicotinamide riboside is well tolerated and elevates NAD+ in healthy middle-aged and older adults (Nature Communications, via NIH PubMed Central)
- Nicotinamide riboside increases NAD+ levels in the human brain (via NIH PubMed Central)
- Intravenous NAD+ in heart failure caused by ischemic cardiomyopathy: a randomized, placebo-controlled trial (PubMed)
Bring the research questions to a consultation
APRM Solutions offers NAD+ by IV and intramuscular injection, always after a candidacy evaluation, and the team is glad to share what the latest research means for your goals. Call (475) 267-6200 or arrange a consultation to start with the right conversation about whether NAD+ fits your goals.
This guide is for education only and is not medical advice. Individual suitability for NAD+ therapy is decided only through an evaluation with a clinician, and emerging therapies should be discussed with the medical team before any treatment.
Appointments & insurance questions welcome
NAD+ questions that a search cannot answer?
Bring them to a consultation. The team will walk you through the latest research, the sourcing and how NAD+ can fit your goals.
New and existing patients welcome. Please call to confirm current hours and availability.
Online scheduling
Book a Consultation
Choose a time that works for you and schedule directly online. Prefer to talk first? Call APRM Solutions at (475) 267-6200.
